Suchergebnisse - "Cook, Gordon"

PubPharm (19)

1

Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma : frailty subgroup analysis of MAIA

enthalten in: Leukemia | 2022

von Facon, T. | Cook, G. | Usmani, S. | +25

2

Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE

enthalten in: Blood | 2022

von San-Miguel, J. | Avet-Loiseau, H. | Paiva, B. | +24

CommentIn: Blood. 2022 Jan 27;139(4):469-471. - PMID 35084473

3

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US

enthalten in: Annals of hematology | 2021

von Davies, F. | Rifkin, R. | Costello, C. | +24

4

Health-related quality of life in patients with relapsed or refractory multiple myeloma : treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial

enthalten in: British journal of haematology | 2021

von Plesner, T. | Dimopoulos, M. | Oriol, A. | +15

5

Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma : a cytogenetic subgroup analysis of POLLUX

enthalten in: Blood cancer journal | 2020

von Kaufman, J. | Dimopoulos, M. | White, D. | +26

6

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma : extended follow-up of POLLUX, a randomized, open-label, phase 3 study

enthalten in: Leukemia | 2020

von Bahlis, N. | Dimopoulos, M. | White, D. | +16

7

Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age : subgroup analysis of the phase 3 CASTOR and POLLUX studies

enthalten in: Haematologica | 2020

von Mateos, M. | Spencer, A. | Nooka, A. | +16

8

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma : updated analysis of POLLUX

enthalten in: Haematologica | 2018

von Dimopoulos, M. | San-Miguel, J. | Belch, A. | +30

9

The use of single armed observational data to closing the gap in otherwise disconnected evidence networks : a network meta-analysis in multiple myeloma

enthalten in: BMC medical research methodology | 2018

von Schmitz, S. | Maguire, �. | Morris, J. | +11

10

A question of class : Treatment options for patients with relapsed and/or refractory multiple myeloma

enthalten in: Critical reviews in oncology/hematology | 2018

von Cook, G. | Zweegman, S. | Mateos, M. | +2